Healthcare & PharmaceuticalsS.Korea to begin producing Novavax COVID-19 vaccine as early as June
ReutersHyonhee Shin
3 minutes read
A woman holds a small bottle labelled with a Coronavirus COVID-19 Vaccine sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic
South Korea said on Monday it plans to begin local production of Novavax Inc s (NVAX.O) COVID-19 vaccine as early as June, while five domestic companies aim to start late stage clinical trials of their own shots in the second half of this year.
The announcements came after President Moon Jae-in hosted a special meeting on anti-virus efforts and vaccine development as the country fears a possible fourth wave of infections.
South Korea to begin producing Novavax COVID-19 vaccine as early as June reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
2 Min Read
SEOUL (Reuters) - South Korea said on Monday it plans to begin local production of Novavax Inc’s COVID-19 vaccine as early as June, while five domestic companies aim to start late stage clinical trials of their own shots in the second half of this year.
FILE PHOTO: A woman holds a small bottle labelled with a Coronavirus COVID-19 Vaccine sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic
The announcements came after President Moon Jae-in hosted a special meeting on anti-virus efforts and vaccine development as the country fears a possible fourth wave of infections.
Article content
SEOUL Five South Korean companies have launched clinical trials for their coronavirus vaccines, aiming to enter the third phase of trials in the second half of this year, the health ministry said on Monday.
The five are SK Bioscience Co, EuBiologics Co , Cellid Co, Genexine Inc and GeneOne Life Science.
We apologize, but this video has failed to load.
Try refreshing your browser, or S.Korean companies begin COVID-19 vaccine trials -Yonhap Back to video
The government plans to provide 68.7 billion won ($61.1 million) to support the companies’ vaccine development, the ministry said in a statement.
The ministry also said that SK Bioscience will be able to begin manufacturing COVID-19 vaccines developed by Novavax Inc as early as June, which it said would ease any potential supply shortages in the face of global production delays.
South Korean companies begin COVID-19 vaccine trials: Yonhap metro.us - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from metro.us Daily Mail and Mail on Sunday newspapers.